3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
7
Carcinoma, Non-Small-Cell Lung
7
Ovarian Neoplasms
5
Endometrial Neoplasms
5
Breast Neoplasms
5
Fallopian Tube Neoplasms
4
Adenocarcinoma Of Esophagus
4
Pancreatic Neoplasms
3
Neoplasm Metastasis
3
Esophageal Neoplasms
3
Cholangiocarcinoma
3
Triple Negative Breast Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Melanoma
2
Esophageal Squamous Cell Carcinoma
2
Colorectal Neoplasms
2
Carcinoma, Transitional Cell
2
Brenner Tumor
2
Urinary Bladder Neoplasms
1
Small Cell Lung Carcinoma
1
Sinonasal Squamous Cell Carcinoma
1
Rectal Neoplasms
1
Pancreatic Cystic Neoplasm
1
Oropharyngeal Neoplasms
1
Neoplasms
1
Mouth Neoplasms
1
Metastatic Pancreatic Ductal Adenocarcinoma
1
Locally Advanced Cervical Adenocarcinoma
1
Laryngeal Neoplasms
1
Gallbladder Neoplasms
1
Interventions
Magnetic Resonance Spectroscopy
3
Cyclophosphamide
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
ivosidenib
2
X-Rays
2
Vincristine
2
Temozolomide
2
Specimen Handling
2
Radiation
2
Phantoms, Imaging
2
Nuclear Medicine Department, Hospital
2
Ifosfamide
2
Etoposide
2
Eflornithine
2
Doxorubicin
2
Congresses as Topic
2
trifluridine tipiracil drug combination
1
tazemetostat
1
talazoparib
1
palbociclib
1
olaparib
1
liposomal doxorubicin
1
larotrectinib
1
irinotecan sucrosofate
1
ganitumab
1
fludarabine phosphate
1
fludarabine
1
etoposide phosphate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Sarcoma, Ewing
×
Taxes
×
30 days
×
Clear all
No trials found.